"By addressing a leading cause of failure in the drug development pipeline, our award-winning nanoparticle engineering technology could be a game-changer for the industry and improve patients’ quality of life."
JUPITER, Fla. (PRWEB) December 02, 2020
Advancements with Ted Danson will focus on recent improvements in nanotechnology and drug engineering on an upcoming episode, scheduled to broadcast on December 12, 2020 at 2:30PM (ET), via CNBC.
With a focus on Nanoform, an innovative nanoparticle medicine-enabling company that supplies unique drug particle engineering services, the show will educate viewers about its multi-patented CESS® technology. It will further explore the potential for Nanoform’s award-winning CESS® process to double the number of lead compounds progressing into clinic.
Viewers will see how the advanced production of nanoparticles provides pharmacokinetic improvements, commercial opportunities, and novel avenues for drug delivery.
“By addressing a leading cause of failure in the drug development pipeline, our award-winning nanoparticle engineering technology could be a game-changer for the industry and improve patients’ quality of life. We are delighted to partner with Advancements to explore the power of our innovative technology on a global stage,” said Professor Edward Hæggström, Nanoform CEO.
Audiences will also learn how Nanoform helps its partners to overcome drug development challenges in order to rapidly progress novel drugs to market.
“Nanoform’s physics-based approach produces pure and stable nanoparticles as small as 10 nm. This could prove to be revolutionary for both patients and the environment. We look forward to sharing this truly amazing technology with our viewers,” said Richard Simon, producer for the Advancements series.
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The Company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.
For more information please visit http://www.nanoform.com.
About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.
Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.
For more information, please visit http://www.AdvancementsTV.com or call Richard Simon at 866-496-4065.